We are live on ! Find out more
CERE

Cerevel Therapeutics Holdings, Inc. Common Stock
CERE

Delisted

CERE was delisted on the 31st of July, 2024.

Back to rankings

2 hedge funds and large institutions have $20.7K invested in Cerevel Therapeutics Holdings, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 228 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

99% less funds holding

Funds holding: 231 → 2 (-229)

100% less funds holding in top 10

Funds holding in top 10: 16 → 0 (-16)

100% less capital invested

Capital invested by funds: $6.42B → $20.7K (-$6.42B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 228

Holders
2
Holders Change
-229
Holders Change %
-99.13%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
-16
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
1
Reduced
1
Closed
228
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BTI
Blue Trust Inc
Georgia
+$297

Top Sellers

Rank Fund Capital Flow
1
BCI
Bain Capital Investors
Massachusetts
-$2.69B
2
PA
Perceptive Advisors
New York
-$441M
3
ACA
Avoro Capital Advisors
New York
-$308M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$293M
5
BlackRock
BlackRock
New York
-$146M
Name Holding Trade Value Shares
Change 		Change in
Stake
CSS
101
Cubist Systematic Strategies
Connecticut
– -$2.97M -72,546 Closed
N
102
Natixis
France
– -$2.94M -71,789 Closed
GI
103
GAMCO Investors
Connecticut
– -$2.43M -59,350 Closed
HighTower Advisors
104
HighTower Advisors
Illinois
– -$2.36M -57,988 Closed
Invesco
105
Invesco
Georgia
– -$2.34M -57,337 Closed
Allianz Asset Management
106
Allianz Asset Management
Germany
– -$2.25M -55,000 Closed
T. Rowe Price Associates
107
T. Rowe Price Associates
Maryland
– -$2.18M -53,401 Closed
OR
108
Olympiad Research
Connecticut
– -$2.14M -52,423 Closed
Barclays
109
Barclays
United Kingdom
– -$2.08M -50,865 Closed
AGM
110
Alpine Global Management
New York
– -$2.04M -50,000 Closed
VI
111
Vestcor Inc
New Brunswick, Canada
– -$2.04M -50,000 Closed
Ohio Public Employees Retirement System (OPERS)
112
Ohio Public Employees Retirement System (OPERS)
Ohio
– -$1.93M -47,292 Closed
State of New Jersey Common Pension Fund D
113
State of New Jersey Common Pension Fund D
New Jersey
– -$1.88M -45,897 Closed
GC
114
Guggenheim Capital
Illinois
– -$1.83M -44,847 Closed
D.E. Shaw & Co
115
D.E. Shaw & Co
New York
– -$1.82M -44,442 Closed
VI
116
Versor Investments
New York
– -$1.81M -44,194 Closed
Mirae Asset Global ETFs Holdings
117
Mirae Asset Global ETFs Holdings
Hong Kong
– -$1.75M -42,761 Closed
SSA
118
Schonfeld Strategic Advisors
New York
– -$1.74M -42,575 Closed
AA
119
AlphaCentric Advisors
Puerto Rico
– -$1.74M -42,500 Closed
CL
120
CSS LLC
Illinois
– -$1.72M -42,011 Closed
EAM
121
Erste Asset Management
Austria
– -$1.62M -40,000 Closed
GCL
122
Glazer Capital LLC
New York
– -$1.64M -40,000 Closed
Walleye Capital
123
Walleye Capital
New York
– -$1.64M -40,000 Closed
AG
124
Algert Global
California
– -$1.63M -39,742 Closed
New York State Common Retirement Fund
125
New York State Common Retirement Fund
New York
– -$1.62M -39,604 Closed
3 4
5
6 7

CERE Hedge Fund Activity: Q3 2024 in Review

2 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) for Q3 2024, worth a combined $20.7K — down 100% from $6.42B a quarter earlier.

Sellers outnumbered buyers: 228 funds closed out of CERE and 0 opened new positions — a net loss of 228 holders — while 1 trimmed existing stakes and 1 added.

The largest buyer was Blue Trust Inc, adding an estimated $297. The largest seller was Bain Capital Investors, exiting entirely with an estimated $2.69B sold.

  • 2 institutional investors held Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) as of Q3 2024, down from 231 in Q2 2024.
  • Funds reported $20.7K of Cerevel Therapeutics Holdings, Inc. Common Stock stock for Q3 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Cerevel Therapeutics Holdings, Inc. Common Stock positions in Q3 2024 and 228 closed out, a net change of -228 holders.
  • The largest Cerevel Therapeutics Holdings, Inc. Common Stock buyer in Q3 2024 was Blue Trust Inc, an estimated $297 added.
  • The largest Cerevel Therapeutics Holdings, Inc. Common Stock seller in Q3 2024 was Bain Capital Investors, an estimated $2.69B sold.

Based on aggregated 13F filings for Q3 2024.